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Research Note 
Is plastoquinone10•0 x an antioxidant marker 
of red wines? 
ANNA GvozDJAKov A, J. KucHARSKA, P. DuRISIN 
and E. MINARIK 
S u m m a r y : Antioxidant activities of 20 different types 
of Slovak wines were examined. For the first time evidence of 
plastoquinone tO-ox (PQw-ox) in red wines was documented. Twice 
higher levels of a.-tocopherol (vitamin E) were determined in 
red wine varieties in comparison to white wine varieties. 
Enzymatic actitivities of superoxidedismutase (SOD) in all red 
wine varieties were higher compared to white wines; in some 
white wines they were not detectable. 
The beneficial effects of antioxidants are discussed, espe-
cially the role of coenzyme Qw (analogue of plant PQw-ox), vi-
tamin E and SOD in preventing cardiovascular diseases. It is 
supposed that PQIO-ox could be an antioxidant marker of red 
wines. To prove the protective effect of a moderate consumption 
of red wine in human cardiology further studies are required. 
K e y w o r d s : wine, plastoquinonew-ox. vitamin E, 
superoxidedismutase, human health. 
Introduction: Moderate daily wine consumption es-
pecially of red wine lowers the arteriosclerosis (disease of 
arteries) development and coronary heart disease (CHD) 
mortality (KLATSKY et al. 1990). The protective effect of 
wine has been attributed both to the content of several natu-
rally occurring compounds like "fungicides", tannins, 
anthocyanins, phenolic flavonoids and to the low alcohol 
content (TROUP and HUTION 1994, DEMROW et al. 1995). 
However, high doses of alcohol increase the risk of CHD 
(FRIEDMAN and KIMBALL 1986) and initiate the development 
of alcohol cardiomyopathy (GvozDJAK et al. 1973). 
In view of the occurrence of antioxidants in wines the 
aim of this study was to determine plasto-quinone10-ox 
(PQIO-ox), a.-tocopherol and superoxide-dismutase (SOD) 
in some Slovak varietal wines. 
Plastoquinone is the plant form of coenzyme Q in 
eucaryotic cells and it has an important function in the 
process of photosynthesis of green plants. The mechanism 
of ATP synthesis in chloroplast during photosynthesis is 
similar to oxidative phosphorylation in animal cells - it is 
driven by a protonmotive force and CoQ participates in 
this process. 
Materials and methods: S a m p 1 e s : 20 different 
varietal wines from the Slovakian vintage 1994 (Table). 
A n a I y t i c a 1 t e c h n i q u e : Plastoquinone10-ox 
and a.-tocopherol were determined simultaneously by a 
modified HPLC method (LKB Sweden) according to 
TANAKA et al. (1982) and LANG et al. (1986) with a 
spectrophotometric detection at 275 nm. Elution was per-
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formed with the mobile phase consisting of methanol-
acetonitrile - ethanol (6:2:2) at a flow rate of 0.65 mVmin. 
S a m p I e p r e p a r a t i o n : 1.0 ml of sample was 
vortexed for 5 min with the extraction mixture hexane-
ethanol (5:2), the hexane layer was evaporated under a 
gentle stream of N2 and residues were dissolved in 96 % 
ethanol. 20 )ll of the extract was injected into a Separon 
SGX C18, 7 )lM (150 x 3 mm) column. External standards 
of ubi-quinone10 (CoQIO) and a.-tocopherol (Sigma) were 
used. SOD activity was determined spectrophotometrically 
according to FLOHE and OTIING ( 1984 ). 
Tab I e 
Samples of Slovakian wines, vintage 1994 
Sample No. Variety Wine type 
1 Limberger red 
2 St. Laurent-Limberger red 
3 St. Laurent red 
4 Limberger red 
5 Limberger red 
6 Cabernet Sauvignon rose 
7 Muller-Thurgau white 
8 Muller-Thurgau white 
9 Riesling white 
10 Muller-Thurgau white 
11 Green Veltiner white 
12 Welsh Riesling white 
13 Muller-Thurgau white 
14 Pinot blanc white 
15 Riesling white 
16 Muscat Ottonel white 
17 Riesling white 
18 Riesling white 
19 Riesling white 
20 Riesling white 
Results: Plastoquinonew-ox was detectable only in 
samples of red wines in concentrations of 23.0- 29.0 )lg/1, 
but not in white and rose wines (Figure, a). 
The concentration of a.-tocopherol varied from 132 to 
788 )lg/1, in Welsh Riesling a.-tocopherol was not detect-
able. The average concentrations in red wines were 589 
f.Lg/1, in white wines 385 )lg/1 and in the rose wine 448 )lg/1 
(Figure, b). 
SOD activity varied from 47.0 to 65.0 IV SOD/ml in 
all red wines. In white wines the activity was 0- 35.0 IV 
SOD/ml; no activity could be found in wine nos 10, 14, 20 
and in the rose wine (Figure, c). 
Discussion: The cardioprotective effect of wine, es-
pecially of red wine, has been shown by several authors. 
DE WHALLEY et al. (1990) and STRUCK et al. (1994) found 
the antioxidative effect of phenolic substances in red wines. 
These substances reduce low density lipoprotein choles-
terol oxidation in human plasma and by this mechanism 
act against the development of arteriosclerosis. The ben-
eficial antiarteriosclerotic effect of a moderate daily con-
sumption of red wine (400 ml daily during 2 weeks) by 
increasing high density lipoproteins in human plasma has 
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been proved by LAVY et al. (1994). FRANKEL et al. (1993) 
found a decrease of lipid peroxidation in human plasma 
by quercetin which occurs in red wine. Beneficial effects 
of red wine are described also by other authors (P ATIICHIS 
et al. 1993). These effects may include an antioxidative 
activity. 
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3 months to adult rats (GvozDJAKovA et al. 1991), and is 
important in the therapy of mitochondrial diseases 
(GvozDJAKovA et al. 1994). 
Conclusion: We suggest that plastoquinone ID-ox could 
be the antioxidant marker of red wines. Regular, moderate 
red wine consumption can serve as an additional source of 
antioxidants (a-tocopherol, PQ10) and antioxidative en-
zyme-superoxidedismutase. The beneficial effects of these 
compounds in red wines to prevent cardiovascular diseases 
require further studies. 
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Figure: a) plastoquinone (PQto-ox) content, b) a-tocopherol 
content, c) superoxidedismutase (SOD) activity in Slovak 
varietial wines. Nos of wine samples see Table. 
Antioxidative properties were also shown for other 
components in wines which have not been described yet. 
We have proved the presence of plastoquinone10-ox• 
a-tocopherol and superoxidase activity. PQIO-ox was de-
tected in all types of red wine while in white and rose 
wines this compound did not occur. A lack of coenzyme Q, 
CoQ, an enzyme taking part in the phosphorylation proc-
ess in human cells, was found being implicated in some 
myocardial diseases (FoLKERS 1993). Long-term adminis-
tration of CoQ has an protective effect in myocardial 
ischemia (KucHARSKA et al. 1994), improves mitochondrial 
bioenergetics of the heart muscle after administration for 
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